Letter to FDA: Temporary Blood Guidances in Place During COVID-19 Pandemic

In April of 2020 FDA issued three guidance documents which modified recommendations for blood collections relating to HIV, Malaria and Alternative Procedures for the duration of the COVID-19 public health emergency. In a letter to the FDA, ABC submitted comments in support of making the three blood guidances permanent – beyond the duration of the public health emergency and to ensure that there is no gap between the time the PHE expires and the time revised guidances are released to avoid unnecessary negative impacts on blood center operations and computer systems.